quinoxalines has been researched along with Eyelid Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bétrian, S; Delord, JP; Gomez-Roca, C; Sibaud, V; Vigarios, E | 1 |
| Bonini, S; Bucci, MG; Centofanti, M; Manni, G; Oddone, F; Parravano, M; Sacchetti, M | 1 |
2 other study(ies) available for quinoxalines and Eyelid Diseases
| Article | Year |
|---|---|
Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.
Topics: Eyelashes; Eyelid Diseases; Fibroblast Growth Factors; Glioblastoma; Humans; Male; Middle Aged; Onycholysis; Pyrazoles; Quinoxalines; Severity of Illness Index; Urinary Bladder Neoplasms | 2017 |
Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Demography; Dermatitis, Allergic Contact; Drug Hypersensitivity; Eyelid Diseases; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Retrospective Studies; Risk Factors | 2004 |